Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.055 USD | +3.18% | -2.76% | -37.03% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.08B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 6.95 x |
P/E ratio 2024 * |
-5.15
x | P/E ratio 2025 * |
-7.77
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | +3.18% | ||
1 week | -2.76% | ||
Current month | +10.19% | ||
1 month | -16.56% | ||
3 months | -40.63% | ||
6 months | -6.78% | ||
Current year | -37.03% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Christian Itin
CEO | Chief Executive Officer | 59 | 14-09-30 |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4.07 | +3.56% | 2,575,944 |
24-05-15 | 3.93 | 0.00% | 984,418 |
24-05-14 | 3.93 | -2.00% | 1,008,063 |
24-05-13 | 4.01 | +0.50% | 1,062,536 |
24-05-10 | 3.99 | -4.32% | 1,024,007 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.03% | 1.08B | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.06% | 22.28B | |
-11.90% | 22.41B | |
-4.73% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- AUTL Stock